Michaela K.
- Country
- Germany
- Department
- ITMP
Research Overview
- Baricitinib Versus TNF Inhibitors for Venous Thromboembolism Risk in Rheumatoid Arthritis: Phase 3b/4 Active-Controlled Study
- Efficacy and Safety of Targeted Therapeutic Strategies in Adults with Rheumatoid Arthritis: A Randomized, Double‑Blind, Placebo‑Controlled Study
- A Phase II, randomised, placebo-controlled, double-blind, parallel-group, efficacy and safety study of at least 48 weeks of oral BI 685509 treatment in adults with progressive systemic sclerosis
Data & Insights
Has run more than one trial at 96 of 272 partner sites.
Specializations
Autoimmune Rheumatic Conditions
The investigator specializes in treating complex systemic autoimmune disorders, with particular focus on systemic lupus erythematosus (SLE) and its complications, including lupus nephritis.
- Lupus Management and Innovation
- Kidney Complications in SLE
- Novel Therapeutic Approaches
Their expertise extends to evaluating emerging treatments for moderate to severe manifestations of these conditions.
Systemic Sclerosis Research
The investigator has developed significant expertise in treating diffuse cutaneous systemic sclerosis (dcSSc), focusing on innovative approaches to manage this challenging condition.
- Lung Function Assessment
- Cutaneous Manifestations
- Disease Progression Monitoring
Their work encompasses evaluation of novel therapeutic agents targeting various aspects of systemic sclerosis.
Inflammatory Conditions
The investigator demonstrates expertise in treating psoriatic arthritis and inflammatory myopathies, with particular attention to treatment-resistant cases.
- Enthesitis Management
- Refractory Myopathies
- Advanced Therapeutic Options
Their focus includes ultrasound-confirmed diagnosis and monitoring of inflammatory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.